Issue/opportunity

Our client, a multinational life sciences company, struggled with fragmented pharmacometrics modeling and simulation practices across its legacy companies and global regions. The lack of standardized workflows and systems led to inefficiencies, reduced research quality, revenue loss, and strained relationships with external partners.

Approach/outcomes

• Assessed current-state processes, systems, and roles to identify inefficiencies, redundancies, and future-state opportunities.
• Redesigned and optimized global pharmacometrics processes across clinical pharmacology, quality, data programming, statistics, business operations, and project management.
• Developed a centralized digital PMx roadmap as a single source of truth, including standardized workflows, templates, tools, and guidance documents.
• Created and launched an interactive performance support tool with a custom landing page to drive global user adoption.
• Designed internal branding and enabled global deployment of new process optimization technology.
• Implemented global training and change management with 90% adoption across 120+ employees.
• Reduced clinical data analysis and reporting cycle times by 38% and 15% through standard analysis plan and reporting templates.
• Improved modeling and simulation process efficiency by 45% and increased annual revenue by $4.2M.